Laporan Laba Rugi (TTM)
Laporan Laba Rugi Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 4 | 4 | 6 | 6 | 6 | 9 | 12 | 18 | 27 | 71 | 71 | 71 | 60 | 18 | 141 | 175 | 178 | 180 | 65 |
| Change (%) | 24.31 | -8.26 | 71.41 | 0.16 | -1.36 | 51.08 | 26.30 | 49.47 | 54.80 | 162.17 | -0.57 | 0.44 | -15.19 | -69.55 | 670.56 | 23.74 | 1.71 | 0.90 | -63.77 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 86 | 92 | 95 | 103 | 107 | 111 | 123 | 129 | 30 | 128 | 117 | 112 | 221 | 127 | 136 | 147 | 143 | 149 | 144 | 129 |
| Change (%) | 6.30 | 3.54 | 8.87 | 4.01 | 3.47 | 11.02 | 4.76 | -77.16 | 332.90 | -8.77 | -4.10 | 97.79 | -42.76 | 7.64 | 7.70 | -2.38 | 4.17 | -3.67 | -10.42 | |
| % of Revenue | 2,705.56 | 2,313.49 | 2,611.13 | 1,658.39 | 1,722.20 | 1,806.64 | 1,327.62 | 1,101.24 | 168.24 | 470.48 | 163.71 | 157.91 | 310.96 | 209.87 | 741.74 | 103.67 | 81.79 | 83.77 | 79.97 | 197.73 |
| Gross Operating Profit | -83 | -88 | -91 | -97 | -101 | -105 | -114 | -117 | -12 | -101 | -45 | -41 | -150 | -66 | -118 | -5 | 32 | 29 | 36 | -64 |
| Change (%) | 5.60 | 4.07 | 6.38 | 4.26 | 3.77 | 8.68 | 3.01 | -89.81 | 740.39 | -54.91 | -9.63 | 265.90 | -55.83 | 77.89 | -95.59 | -713.91 | -9.32 | 24.49 | -276.78 | |
| % of Revenue | -2,605.56 | -2,213.49 | -2,511.13 | -1,558.39 | -1,622.20 | -1,706.64 | -1,227.62 | -1,001.24 | -68.24 | -370.48 | -63.71 | -57.91 | -210.96 | -109.87 | -641.74 | -3.67 | 18.21 | 16.23 | 20.03 | -97.73 |
| SG&A | 43 | 46 | 50 | 54 | 56 | 57 | 60 | 61 | 63 | 63 | 59 | 61 | 68 | 64 | 70 | 72 | 70 | 81 | 83 | 84 |
| Change (%) | 5.80 | 9.95 | 6.44 | 4.05 | 2.76 | 5.21 | 1.68 | 2.68 | 0.70 | -7.07 | 4.13 | 10.62 | -4.99 | 7.93 | 3.02 | -2.86 | 16.78 | 2.32 | 1.28 | |
| % of Revenue | 1,359.48 | 1,157.02 | 1,386.70 | 861.10 | 894.56 | 931.94 | 649.00 | 522.48 | 358.93 | 233.49 | 82.76 | 86.68 | 95.46 | 106.94 | 378.99 | 50.67 | 39.78 | 45.67 | 46.31 | 129.47 |
| R&D | 105 | -105 | ||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | 596.88 | -147.27 | ||||||||||||||||||
| OpEx | 129 | 137 | 145 | 157 | 163 | 168 | 184 | 191 | 197 | 191 | 175 | 173 | 184 | 191 | 206 | 218 | 213 | 230 | 227 | 213 |
| Change (%) | 6.13 | 5.68 | 8.03 | 4.03 | 3.23 | 9.05 | 3.75 | 3.47 | -3.05 | -8.21 | -1.34 | 6.42 | 3.67 | 7.73 | 6.12 | -2.54 | 8.29 | -1.55 | -6.13 | |
| % of Revenue | 4,065.04 | 3,470.52 | 3,997.82 | 2,519.49 | 2,616.76 | 2,738.58 | 1,976.62 | 1,623.72 | 1,124.05 | 703.97 | 246.48 | 244.59 | 259.16 | 316.80 | 1,120.73 | 154.34 | 121.57 | 129.44 | 126.29 | 327.19 |
| Operating Income | -126 | -133 | -142 | -151 | -157 | -162 | -174 | -179 | -180 | -164 | -104 | -102 | -113 | -131 | -187 | -77 | -38 | -52 | -47 | -148 |
| Change (%) | 5.67 | 6.09 | 6.40 | 4.19 | 3.41 | 7.45 | 2.55 | 0.45 | -8.70 | -36.42 | -1.86 | 10.56 | 15.53 | 43.38 | -58.98 | -50.89 | 38.83 | -9.90 | 213.16 | |
| % of Revenue | -3,965.04 | -3,370.52 | -3,897.82 | -2,419.49 | -2,516.76 | -2,638.58 | -1,876.62 | -1,523.72 | -1,024.05 | -603.97 | -146.48 | -144.59 | -159.16 | -216.80 | -1,020.73 | -54.34 | -21.57 | -29.44 | -26.29 | -227.19 |
| Interest Expense | -1 | -1 | -2 | -3 | -5 | -6 | ||||||||||||||
| Change (%) | 210.84 | 104.77 | 56.18 | 8.34 | ||||||||||||||||
| % of Revenue | -12.75 | -0.37 | -0.93 | -1.88 | -2.91 | -8.70 | ||||||||||||||
| Net Income | -123 | -130 | -140 | -149 | -156 | -158 | -171 | -176 | -175 | -165 | -114 | -91 | -95 | -114 | -163 | -72 | -45 | -71 | -70 | -170 |
| Change (%) | 5.90 | 7.38 | 6.58 | 4.68 | 1.44 | 7.91 | 3.20 | -0.56 | -5.49 | -31.01 | -20.26 | 4.59 | 19.61 | 43.50 | -55.63 | -38.60 | 59.08 | -1.30 | 142.87 | |
| % of Revenue | -3,858.13 | -3,286.81 | -3,847.09 | -2,391.97 | -2,499.92 | -2,570.99 | -1,836.30 | -1,500.42 | -998.26 | -609.46 | -160.39 | -128.63 | -133.94 | -188.90 | -890.13 | -51.25 | -25.43 | -39.78 | -38.91 | -260.82 |
Source: Capital IQ
